Regardless of the initiating factors, the presence of extranuclear TDP-43 in the vast majority of clinical ALS cases points to this as a critical disease component, and its reduction would likely prove beneficial. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.